Corrigendum to “Microbiome-derived indole-3-lactic acid reduces amyloidopathy through aryl-hydrocarbon receptor activation” [Brain Behav. Immun. 122 (2024) 568–582, (S0889159124005749), (10.1016/j.bbi.2024.08.051)]

The authors regret that in the original published version of the article, in the “2. Materials and Methods” section, specifically under “2.2. Preparation of the microbial strains and metabolites,” the sentence was inaccurately stated as follows: “Each lyophilized bacteria powder was suspended in 1 mL PBS at concentrations of 1 × 10^9 CFU prior to administration. Then, each mouse was given 200 μL of microbial strains daily by oral gavage.” This should be corrected to: “Each lyophilized bacterial powder was suspended in PBS to achieve final concentrations of 1 × 10^9 CFU per 200 μL during the screening phase and 1 × 10^12 CFU per 200 μL during the validation phase, which were then administered daily to each mouse by oral gavage.” The authors would like to apologise for any inconvenience caused.